Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis.
Saved in:
| Title: | Cardiotoxicity Profiles of Osimertinib Compared with Other EGFR Tyrosine Kinase Inhibitors: A Real-World Comparative Incidence Analysis. |
|---|---|
| Authors: | Muhanna Z; School of Medicine, University of Jordan, Amman, Jordan., Al Zyoud M; School of Medicine, University of Jordan, Amman, Jordan., Issa A; School of Medicine, University of Jordan, Amman, Jordan., Awidi M; Roswell Park Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA. muhammadawidi@gmail.com. |
| Source: | Targeted oncology [Target Oncol] 2025 Nov; Vol. 20 (6), pp. 1015-1022. Date of Electronic Publication: 2025 Oct 27. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
